Loading...

Jerry S Powell

Title(s)Professor Emeritus, Hematology and Oncology
SchoolUniversity of California, Davis
Phone916-734-3772
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Diego VP, Luu BW, Hofmann M, Dinh LV, Almeida M, Powell JS, Rajalingam R, Peralta JM, Kumar S, Curran JE, Sauna ZE, Kellerman R, Park Y, Key NS, Escobar MA, Huynh H, Verhagen AM, Williams-Blangero S, Lehmann PV, Maraskovsky E, Blangero J, Howard TE. Quantitative HLA-class-II/Factor VIII (FVIII) Peptidomic Variation in Dendritic Cells Correlates with the Immunogenic Potential of Therapeutic FVIII Proteins in Hemophilia A. J Thromb Haemost. 2019 Sep 25. PMID: 31556206.
      View in: PubMed
    2. Klamroth R, Simpson M, von Depka-Prondzinski M, Gill JC, Morfini M, Powell JS, Santagostino E, Davis J, Huth-Kühne A, Leissinger C, Neumeister P, Bensen-Kennedy D, Feussner A, Limsakun T, Zhou M, Veldman A, St Ledger K, Blackman N, Pabinger I. Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia A. Haemophilia. 2016 Sep; 22(5):730-8. PMID: 27434619.
      View in: PubMed
    3. Powell JS. Longer-acting clotting factor concentrates for hemophilia. J Thromb Haemost. 2015 Jun; 13 Suppl 1:S167-75. PMID: 26149018.
      View in: PubMed
    4. Powell JS. Lasting power of new clotting proteins. Hematology Am Soc Hematol Educ Program. 2014 Dec 05; 2014(1):355-63. PMID: 25696879.
      View in: PubMed
    5. Powell JS, Apte S, Chambost H, Hermans C, Jackson S, Josephson NC, Mahlangu JN, Ozelo MC, Peerlinck K, Pasi J, Perry D, Ragni MV, Wang X, Jiang H, Li S, Cristiano LM, Innes A, Nugent K, Brennan A, Luk A, Allen G, Pierce GF, Robinson B. Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study. Br J Haematol. 2015 Jan; 168(1):124-34. PMID: 25208598.
      View in: PubMed
    6. Powell J, Shapiro A, Ragni M, Negrier C, Windyga J, Ozelo M, Pasi J, Baker R, Potts J, Li S, Mei B, Pierce GF, Robinson B. Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates. Br J Haematol. 2015 Jan; 168(1):113-23. PMID: 25209873.
      View in: PubMed
    7. Ducore JM, Miguelino MG, Powell JS. Alprolix (recombinant Factor IX Fc fusion protein): extended half-life product for the prophylaxis and treatment of hemophilia B. Expert Rev Hematol. 2014 Oct; 7(5):559-71. PMID: 25142322.
      View in: PubMed
    8. Miguelino MG, Powell JS. Clinical utility and patient perspectives on the use of extended half-life rFIXFc in the management of hemophilia B. Patient Prefer Adherence. 2014; 8:1073-83. PMID: 25143713.
      View in: PubMed
    9. Janbain M, Nugent DJ, Powell JS, St-Louis J, Frame VB, Leissinger CA. Use of Factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures. Transfusion. 2015 Jan; 55(1):45-50. PMID: 25070582.
      View in: PubMed
    10. Lalezari S, Coppola A, Lin J, Enriquez MM, Tseneklidou-Stoeter D, Powell J, Ingerslev J. Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study. Haemophilia. 2014 May; 20(3):354-61. PMID: 24847524.
      View in: PubMed
    11. Coyle TE, Reding MT, Lin JC, Michaels LA, Shah A, Powell J. Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A. J Thromb Haemost. 2014 Apr; 12(4):488-96. PMID: 24843882.
      View in: PubMed
    12. Powell JS, Pasi KJ, Ragni MV, Ozelo MC, Valentino LA, Mahlangu JN, Josephson NC, Perry D, Manco-Johnson MJ, Apte S, Baker RI, Chan GC, Novitzky N, Wong RS, Krassova S, Allen G, Jiang H, Innes A, Li S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Nugent K, Vigliani G, Brennan A, Luk A, Pierce GF. Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. N Engl J Med. 2013 Dec 12; 369(24):2313-23. PMID: 24304002.
      View in: PubMed
    13. Mahlangu J, Powell JS, Ragni MV, Chowdary P, Josephson NC, Pabinger I, Hanabusa H, Gupta N, Kulkarni R, Fogarty P, Perry D, Shapiro A, Pasi KJ, Apte S, Nestorov I, Jiang H, Li S, Neelakantan S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Dodd N, Nugent K, Vigliani G, Luk A, Brennan A, Pierce GF. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A. Blood. 2014 Jan 16; 123(3):317-25. PMID: 24227821.
      View in: PubMed
    14. Kaufman RJ, Powell JS. Molecular approaches for improved clotting factors for hemophilia. Blood. 2013 Nov 21; 122(22):3568-74. PMID: 24065241.
      View in: PubMed
    15. Soucie JM, Monahan PE, Kulkarni R, De Staercke C, Recht M, Chitlur MB, Gruppo R, Hooper WC, Kessler C, Manco-Johnson MJ, Powell J, Pyle M, Riske B, Sabio H, Trimble S. Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates. Transfusion. 2013 May; 53(5):1143-4. PMID: 23659532.
      View in: PubMed
    16. Valentino LA, Allen G, Gill JC, Hurlet A, Konkle BA, Leissinger CA, Luchtman-Jones L, Powell J, Reding M, Stine K. Case studies in the management of refractory bleeding in patients with haemophilia A and inhibitors. Haemophilia. 2013 May; 19(3):e151-66. PMID: 23374141.
      View in: PubMed
    17. Lane J, McLaren PJ, Dorrell L, Shianna KV, Stemke A, Pelak K, Moore S, Oldenburg J, Alvarez-Roman MT, Angelillo-Scherrer A, Boehlen F, Bolton-Maggs PH, Brand B, Brown D, Chiang E, Cid-Haro AR, Clotet B, Collins P, Colombo S, Dalmau J, Fogarty P, Giangrande P, Gringeri A, Iyer R, Katsarou O, Kempton C, Kuriakose P, Lin J, Makris M, Manco-Johnson M, Tsakiris DA, Martinez-Picado J, Mauser-Bunschoten E, Neff A, Oka S, Oyesiku L, Parra R, Peter-Salonen K, Powell J, Recht M, Shapiro A, Stine K, Talks K, Telenti A, Wilde J, Yee TT, Wolinsky SM, Martinson J, Hussain SK, Bream JH, Jacobson LP, Carrington M, Goedert JJ, Haynes BF, McMichael AJ, Goldstein DB, Fellay J. A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Hum Mol Genet. 2013 May 01; 22(9):1903-10. PMID: 23372042.
      View in: PubMed
    18. Kaufman RJ, Powell JS. Molecular approaches for improved clotting factors for hemophilia. Hematology Am Soc Hematol Educ Program. 2013; 2013:30-6. PMID: 24319159.
      View in: PubMed
    19. Powell J, Martinowitz U, Windyga J, Di Minno G, Hellmann A, Pabinger I, Maas Enriquez M, Schwartz L, Ingerslev J. Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study. Thromb Haemost. 2012 Nov; 108(5):913-22. PMID: 23014711.
      View in: PubMed
    20. Soucie JM, De Staercke C, Monahan PE, Recht M, Chitlur MB, Gruppo R, Hooper WC, Kessler C, Kulkarni R, Manco-Johnson MJ, Powell J, Pyle M, Riske B, Sabio H, Trimble S. Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening. Transfusion. 2013 Jun; 53(6):1217-25. PMID: 22998193.
      View in: PubMed
    21. Powell JS, Josephson NC, Quon D, Ragni MV, Cheng G, Li E, Jiang H, Li L, Dumont JA, Goyal J, Zhang X, Sommer J, McCue J, Barbetti M, Luk A, Pierce GF. Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients. Blood. 2012 Mar 29; 119(13):3031-7. PMID: 22223821.
      View in: PubMed
    22. Shapiro AD, Ragni MV, Valentino LA, Key NS, Josephson NC, Powell JS, Cheng G, Thompson AR, Goyal J, Tubridy KL, Peters RT, Dumont JA, Euwart D, Li L, Hallén B, Gozzi P, Bitonti AJ, Jiang H, Luk A, Pierce GF. Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients. Blood. 2012 Jan 19; 119(3):666-72. PMID: 22110246.
      View in: PubMed
    23. Kessler CM, Friedman K, Schwartz BA, Gill JC, Powell JS. The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover study. Thromb Haemost. 2011 Aug; 106(2):279-88. PMID: 21725579.
      View in: PubMed
    24. Powell JS. Recombinant factor VIII in the management of hemophilia A: current use and future promise. Ther Clin Risk Manag. 2009 Apr; 5(2):391-402. PMID: 19536318.
      View in: PubMed
    25. Powell J. The next generation of anti-haemophilia factor, factor VIII. Long-lasting protection from spontaneous bleeding, are we there yet? Thromb Haemost. 2008 Sep; 100(3):365-6. PMID: 18766246.
      View in: PubMed
    26. Walsh CE. Prophylaxis for adults with severe haemophilia: a compelling need for evidence-based guidelines. Haemophilia. 2008 Mar; 14(2):385-6. PMID: 18201188.
      View in: PubMed
    27. Powell JS, Nugent DJ, Harrison JA, Soni A, Luk A, Stass H, Gorina E. Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A. J Thromb Haemost. 2008 Feb; 6(2):277-83. PMID: 18039351.
      View in: PubMed
    28. Powell JS. Liposomal approach towards the development of a longer-acting factor VIII. Haemophilia. 2007 Sep; 13 Suppl 2:23-8. PMID: 17685920.
      View in: PubMed
    29. Lambert T, Recht M, Valentino LA, Powell JS, Udata C, Sullivan ST, Roth DA. Reformulated BeneFix: efficacy and safety in previously treated patients with moderately severe to severe haemophilia B. Haemophilia. 2007 May; 13(3):233-43. PMID: 17498071.
      View in: PubMed
    30. Goedert JJ. Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001-2003. Haemophilia. 2005 Sep; 11(5):516-28. PMID: 16128897.
      View in: PubMed
    31. Pimstone NR, Pimstone D, Saicheur T, Powell J, Yu AS. "Wait-and-see": an alternative approach to managing acute hepatitis C with high-dose interferon-alpha monotherapy. Ann Intern Med. 2004 Sep 21; 141(6):W91-2. PMID: 15381541.
      View in: PubMed
    32. Wu F, Jagir M, Powell JS. Long-term correction of hyperglycemia in diabetic mice after implantation of cultured human cells derived from fetal pancreas. Pancreas. 2004 Jul; 29(1):e23-9. PMID: 15211120.
      View in: PubMed
    33. Thompson AR, Gill JC, Ewenstein BM, Mueller-Velten G, Schwartz BA. Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-P). Haemophilia. 2004 Jan; 10(1):42-51. PMID: 14962219.
      View in: PubMed
    34. Gill JC, Ewenstein BM, Thompson AR, Mueller-Velten G, Schwartz BA. Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-P): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy. Haemophilia. 2003 Nov; 9(6):688-95. PMID: 14750934.
      View in: PubMed
    35. Powell JS, Ragni MV, White GC, Lusher JM, Hillman-Wiseman C, Moon TE, Cole V, Ramanathan-Girish S, Roehl H, Sajjadi N, Jolly DJ, Hurst D. Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion. Blood. 2003 Sep 15; 102(6):2038-45. PMID: 12763932.
      View in: PubMed
    36. DiMichele DM, Kroner BL. The North American Immune Tolerance Registry: practices, outcomes, outcome predictors. Thromb Haemost. 2002 Jan; 87(1):52-7. PMID: 11848456.
      View in: PubMed
    37. DeMartini J, Wilson A, Powell JS, Powell CS. Lead arthropathy and systemic lead poisoning from an intraarticular bullet. AJR Am J Roentgenol. 2001 May; 176(5):1144. PMID: 11312168.
      View in: PubMed
    38. Cohen AJ, Kessler CM, Ewenstein BM. Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America. Haemophilia. 2001 May; 7(3):235-41. PMID: 11380626.
      View in: PubMed
    39. Abshire TC, Brackmann HH, Scharrer I, Hoots K, Gazengel C, Powell JS, Gorina E, Kellermann E, Vosburgh E. Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy--International Kogenate-FS Study Group. Thromb Haemost. 2000 Jun; 83(6):811-6. PMID: 10896230.
      View in: PubMed
    40. Powell JS, Bush M, Harrison J, Abildgaard C, Vosburgh E, Thompson AR, Hurst D. Safety and efficacy of solvent/detergent-treated antihaemophilic factor with an added 80 degrees C terminal dry heat treatment in patients with haemophilia A. Haemophilia. 2000 May; 6(3):140-9. PMID: 10792471.
      View in: PubMed
    41. Gershony G, Brock JM, Powell JS. Novel vascular sealing device for closure of percutaneous vascular access sites. Cathet Cardiovasc Diagn. 1998 Sep; 45(1):82-8; discussion 90-1. PMID: 9736360.
      View in: PubMed
    42. Levin LG, Jarvis M, Powell J, Harrison JA, Reisner HM. Induction of human factor VIII inhibitors in rats 2: Fine mapping of rat anti-human rFVIII antibodies. Thromb Haemost. 1996 Dec; 76(6):998-1003. PMID: 8972024.
      View in: PubMed
    43. Mack KD, Walzem RL, Lehmann-Bruinsma K, Powell JS, Zeldis JB. Polylysine enhances cationic liposome-mediated transfection of the hepatoblastoma cell line Hep G2. Biotechnol Appl Biochem. 1996 06; 23(3):217-20. PMID: 8679107.
      View in: PubMed
    44. Jarvis MA, Levin LG, Harrison JA, DePianto DJ, Suzuki CM, Ziaja CL, Brown JE, Jolly KW, Reisner HM, Abildgaard CF, Powell JS. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype. Thromb Haemost. 1996 Feb; 75(2):318-25. PMID: 8815584.
      View in: PubMed
    45. Burke PA, Lehmann-Bruinsma K, Powell JS. Vascular endothelial growth factor causes endothelial proliferation after vascular injury. Biochem Biophys Res Commun. 1995 Feb 06; 207(1):348-54. PMID: 7857288.
      View in: PubMed
    46. Hickman MA, Malone RW, Lehmann-Bruinsma K, Sih TR, Knoell D, Szoka FC, Walzem R, Carlson DM, Powell JS. Gene expression following direct injection of DNA into liver. Hum Gene Ther. 1994 Dec; 5(12):1477-83. PMID: 7711140.
      View in: PubMed
    47. Malone RW, Hickman MA, Lehmann-Bruinsma K, Sih TR, Walzem R, Carlson DM, Powell JS. Dexamethasone enhancement of gene expression after direct hepatic DNA injection. J Biol Chem. 1994 Nov 25; 269(47):29903-7. PMID: 7961986.
      View in: PubMed
    48. Lehmann K, Powell JS. Effect of cilazapril on the proliferative response after vascular damage. J Cardiovasc Pharmacol. 1993; 22 Suppl 4:S19-24. PMID: 7523769.
      View in: PubMed
    49. Hanson SR, Powell JS, Dodson T, Lumsden A, Kelly AB, Anderson JS, Clowes AW, Harker LA. Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension. 1991 Oct; 18(4 Suppl):II70-6. PMID: 1833327.
      View in: PubMed
    50. Clowes AW, Clowes MM, Vergel SC, Müller RK, Powell JS, Hefti F, Baumgartner HR. Heparin and cilazapril together inhibit injury-induced intimal hyperplasia. Hypertension. 1991 Oct; 18(4 Suppl):II65-9. PMID: 1833326.
      View in: PubMed
    51. Osterrieder W, Müller RK, Powell JS, Clozel JP, Hefti F, Baumgartner HR. Role of angiotensin II in injury-induced neointima formation in rats. Hypertension. 1991 Oct; 18(4 Suppl):II60-4. PMID: 1833325.
      View in: PubMed
    52. Powell JS, Muller RK, Baumgartner HR. Suppression of the vascular response to injury: the role of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 1991 May; 17(6 Suppl B):137B-142B. PMID: 1826694.
      View in: PubMed
    53. Clozel JP, Powell JS, Kuhn H, Müller RK, Hefti F, Baumgartner HR. Vascular protection with cilazapril. Drugs. 1991; 41 Suppl 1:62-7. PMID: 1712274.
      View in: PubMed
    54. Powell JS, Rouge M, Müller RK, Baumgartner HR. Cilazapril suppresses myointimal proliferation after vascular injury: effects on growth factor induction in vascular smooth muscle cells. Basic Res Cardiol. 1991; 86 Suppl 1:65-74. PMID: 1827985.
      View in: PubMed
    55. Mason-Garcia M, Beckman BS, Brookins JW, Powell JS, Lanham W, Blaisdell S, Keay L, Li SC, Fisher JW. Development of a new radioimmunoassay for erythropoietin using recombinant erythropoietin. Kidney Int. 1990 Nov; 38(5):969-75. PMID: 2266682.
      View in: PubMed
    56. Resink TJ, Scott-Burden T, Hahn AW, Rouge M, Hosang M, Powell JS, Bühler FR. Specific growth stimulation of cultured smooth muscle cells from spontaneously hypertensive rats by platelet-derived growth factor A-chain homodimer. Cell Regul. 1990 Oct; 1(11):821-31. PMID: 1965150.
      View in: PubMed
    57. Hahn AW, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Bühler FR. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul. 1990 Aug; 1(9):649-59. PMID: 2078571.
      View in: PubMed
    58. Resink TJ, Hahn AW, Scott-Burden T, Powell J, Weber E, Bühler FR. Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun. 1990 May 16; 168(3):1303-10. PMID: 2161221.
      View in: PubMed
    59. Powell JS, Müller RK, Rouge M, Kuhn H, Hefti F, Baumgartner HR. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol. 1990; 16 Suppl 4:S42-9. PMID: 1705627.
      View in: PubMed
    60. Powell JS, Clozel JP, Müller RK, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989 Jul 14; 245(4914):186-8. PMID: 2526370.
      View in: PubMed
    61. Sakariassen KS, Powell JS, Raines EW, Ross R. Selective expression of mRNA encoding platelet-derived growth factor B chain following transfection of foreign genes into cell lines derived from baby hamster kidney. J Cell Biochem. 1989 Jan; 39(1):87-94. PMID: 2654148.
      View in: PubMed
    62. Dubé S, Fisher JW, Powell JS. Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function. J Biol Chem. 1988 Nov 25; 263(33):17516-21. PMID: 3182860.
      View in: PubMed
    63. Broudy VC, Tait JF, Powell JS. Recombinant human erythropoietin: purification and analysis of carbohydrate linkage. Arch Biochem Biophys. 1988 Sep; 265(2):329-36. PMID: 3421710.
      View in: PubMed
    64. Bernstein ID, Singer JW, Andrews RG, Keating A, Powell JS, Bjornson BH, Cuttner J, Najfeld V, Reaman G, Raskind W. Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed. J Clin Invest. 1987 Apr; 79(4):1153-9. PMID: 3470307.
      View in: PubMed
    65. Abkowitz JL, Powell JS, Nakamura JM, Kadin ME, Adamson JW. Pure red cell aplasia: response to therapy with anti-thymocyte globulin. Am J Hematol. 1986 Dec; 23(4):363-71. PMID: 3098093.
      View in: PubMed
    66. Andrews RG, Takahashi M, Segal GM, Powell JS, Bernstein ID, Singer JW. The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursors. Blood. 1986 Nov; 68(5):1030-5. PMID: 3768529.
      View in: PubMed
    67. Powell JS, Berkner KL, Lebo RV, Adamson JW. Human erythropoietin gene: high level expression in stably transfected mammalian cells and chromosome localization. Proc Natl Acad Sci U S A. 1986 Sep; 83(17):6465-9. PMID: 3462706.
      View in: PubMed
    68. Abkowitz JL, Kadin ME, Powell JS, Adamson JW. Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br J Haematol. 1986 May; 63(1):59-67. PMID: 3085703.
      View in: PubMed
    69. Yen YP, Zabala P, Doney K, Clemons G, Gillis S, Powell JS, Adamson JW. Hematopoietic growth factors in human serum. erythroid burst-promoting activity in normal subjects and in patients with severe aplastic anemia. J Lab Clin Med. 1985 Oct; 106(4):384-92. PMID: 4045296.
      View in: PubMed
    70. Delwiche F, Raines E, Powell J, Ross R, Adamson J. Platelet-derived growth factor enhances in vitro erythropoiesis via stimulation of mesenchymal cells. J Clin Invest. 1985 Jul; 76(1):137-42. PMID: 4019772.
      View in: PubMed
    71. Keating A, Powell J, Takahashi M, Singer JW. The generation of human long-term marrow cultures from marrow depleted of Ia (HLA-DR) positive cells. Blood. 1984 Dec; 64(6):1159-62. PMID: 6594169.
      View in: PubMed
    72. Jacobson RJ, Temple MJ, Singer JW, Raskind W, Powell J, Fialkow PJ. A clonal complete remission in a patient with acute nonlymphocytic leukemia originating in a multipotent stem cell. N Engl J Med. 1984 Jun 07; 310(23):1513-7. PMID: 6717542.
      View in: PubMed
    73. Powell JS, Fialkow PJ, Adamson JW. Human mixed cell colonies: unicellular or multicellular origin--analysis by G-6-PD. Br J Haematol. 1984 May; 57(1):89-95. PMID: 6722041.
      View in: PubMed
    74. Adamson JW, Powell JS. The spleen as a source of colony-forming cells in myelofibrosis. Prog Clin Biol Res. 1984; 154:323-34. PMID: 6382301.
      View in: PubMed
    75. Kimura H, Burstein SA, Thorning D, Powell JS, Harker LA, Fialkow PJ, Adamson JW. Human megakaryocytic progenitors (CFU-M) assayed in methylcellulose: physical characteristics and requirements for growth. J Cell Physiol. 1984 Jan; 118(1):87-96. PMID: 6690455.
      View in: PubMed
    76. Singer JW, Keating A, Cuttner J, Gown AM, Jacobson R, Killen PD, Moohr JW, Najfeld V, Powell J, Sanders J. Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: studies of patients with clonal hematopoietic neoplasia. Leuk Res. 1984; 8(4):535-45. PMID: 6471898.
      View in: PubMed
    77. Delwiche F, Garrity MJ, Powell JS, Robertson RP, Adamson JW. High levels of the circulating form of parathyroid hormone do not inhibit in vitro erythropoiesis. J Lab Clin Med. 1983 Oct; 102(4):613-20. PMID: 6311928.
      View in: PubMed
    78. Powell JS, Fialkow PJ, Adamson JW. Polycythemia vera: studies of hemopoiesis in continuous long-term culture of human marrow. J Cell Physiol Suppl. 1982; 1:79-85. PMID: 6950947.
      View in: PubMed